The European cardiology market is estimated to grow significantly at a CAGR of around 6.2% during the forecast period. The market is mainly driven owing to the well-developed healthcare sector and considerably high healthcare expenditure and infrastructure in its economies such as Germany, UK, France and others. The major factor contributing to the European cardiology market is the rising prevalence of CVDs. Unhealthy lifestyle such as smoking, consumption of drugs and alcohol in European countries are the major factors for increasing CVD incidences among men and women. Government initiatives, programs and funding related to increasing awareness toward CVD are also contributing to the growth of the market in the region.

Request a Free Sample of our Report on European Cardiology Market: https://www.omrglobal.com/request-sample/european-cardiology-market

The market is segmented on the basis of Device type, drug type, mechanism, and surgeries type. Based on Device type, the market is segregated angioplasty, cardiovascular stents, cardiovascular catheters, cardiac rhythm management, cardiovascular assistive devices. Angioplasty and vascular stenting are widely adopted procedures in the cardiology market and have a considerable market share. Based on the drug type, the market is segmented into antithrombotic drugs, antidyslipidemic drugs, antihypertensive drugs, and anti-stroke drugs. On the basis of surgeries type, the market is classified into coronary artery bypass grafting, transmyocardial laser revascularization, heart valve repair, arrhythmia treatment, aneurysm repair, and heart transplant.

A Full Report of European Cardiology Market is Available at https://www.omrglobal.com/industry-reports/european-cardiology-market

European Cardiology Market Segmentation

By Device Type
• Angioplasty
• Cardiovascular stents
• Cardiovascular catheters
• Cardiac rhythm management
• Cardiovascular assistive devices

By Drug Type
• Antithrombotic drugs
• Antidyslipidemic drugs
• Antihypertensive drugs
• Anti-stroke drugs

By Mechanism
• Beta blockers
• Beta agonists
• Alpha blockers
• Alpha agonists
• Sodium channel blockers
• Calcium channel blockers
• Vasodilators
• Renin inhibitors
• Angiotensin receptor blockers
• Diuretics
• Thrombolytics

By Surgeries Type
• Coronary artery bypass grafting
• Transmyocardial laser revascularization
• Heart valve repair
• Arrhythmia treatment
• Aneurysm repair
• Heart transplant

Regional Analysis
• UK
• Germany
• Italy
• France
• Spain
• Rest of Europe

Company Profiles
• Abbott Laboratories
• AstraZeneca PLC
• Bayer AG
• Boehringer Ingelheim International GmbH
• F. Hoffmann-La Roche AG
• General Electric Co.
• Medtronic PLC
• Merck KGaA
• Novartis International AG
• Sanofi S.A.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/european-cardiology-market

About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404